[HTML][HTML] Xanthine oxidoreductase: A leading actor in cardiovascular disease drama
Cardiovascular diseases (CVD) are the leading cause of global mortality and their
pathogenesis lies mainly in the atherosclerotic process. There are close connections linking …
pathogenesis lies mainly in the atherosclerotic process. There are close connections linking …
[HTML][HTML] Xanthine oxidoreductase: One enzyme for multiple physiological tasks
Human xanthine oxidoreductase (XOR) is a multiple-level regulated enzyme, resulting from
a complicated evolutionary process that assigned it many physiological roles. The main …
a complicated evolutionary process that assigned it many physiological roles. The main …
[HTML][HTML] Xanthine oxidoreductase in atherosclerosis pathogenesis: Not only oxidative stress
MG Battelli, L Polito, A Bolognesi - Atherosclerosis, 2014 - Elsevier
Endothelial xanthine oxidoreductase (XOR) together with NAD (P) H oxidase and nitric
oxide (NO) synthase plays a physiologic role in inflammatory signalling, the regulation of NO …
oxide (NO) synthase plays a physiologic role in inflammatory signalling, the regulation of NO …
Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications
CE Berry, JM Hare - The Journal of physiology, 2004 - Wiley Online Library
There is substantial evidence that oxidative stress participates in the pathophysiology of
cardiovascular disease. Biochemical, molecular and pharmacological studies further …
cardiovascular disease. Biochemical, molecular and pharmacological studies further …
[HTML][HTML] Chronic kidney disease: Which role for xanthine oxidoreductase activity and products?
The present review explores the role of xanthine oxidoreductase (XOR) in the development
and progression of chronic kidney disease (CKD). Human XOR is a multi-level regulated …
and progression of chronic kidney disease (CKD). Human XOR is a multi-level regulated …
Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options
W Doehner, U Landmesser - Seminars in nephrology, 2011 - Elsevier
The association between increased uric acid (UA) levels and cardiovascular disease (CVD)
has been observed and studied for many decades. The value of UA as an independent …
has been observed and studied for many decades. The value of UA as an independent …
[HTML][HTML] The role of xanthine oxidoreductase and uric acid in metabolic syndrome
Xanthine oxidoreductase (XOR) could contribute to the pathogenesis of metabolic syndrome
through the oxidative stress and the inflammatory response induced by XOR-derived …
through the oxidative stress and the inflammatory response induced by XOR-derived …
[HTML][HTML] Hyperuricemia and endothelial function: From molecular background to clinical perspectives
T Maruhashi, I Hisatome, Y Kihara, Y Higashi - Atherosclerosis, 2018 - Elsevier
Uric acid is the end product of purine metabolism catalyzed by xanthine oxidase in humans.
In the process of purine metabolism, reactive oxygen species, including superoxide, are …
In the process of purine metabolism, reactive oxygen species, including superoxide, are …
Xanthine oxidoreductase in drug metabolism: beyond a role as a detoxifying enzyme
M Giulia Battelli, L Polito, M Bortolotti… - Current medicinal …, 2016 - ingentaconnect.com
The enzyme xanthine oxidoreductase (XOR) catalyzes the last two steps of purine
catabolism in the highest uricotelic primates. XOR is an enzyme with dehydrogenase activity …
catabolism in the highest uricotelic primates. XOR is an enzyme with dehydrogenase activity …
[HTML][HTML] The role of oxidative stress in hyperuricemia and xanthine oxidoreductase (XOR) inhibitors
N Liu, H Xu, Q Sun, X Yu, W Chen, H Wei… - … Medicine and Cellular …, 2021 - hindawi.com
Uric acid is the end product of purine metabolism in humans. Hyperuricemia is a metabolic
disease caused by the increased formation or reduced excretion of serum uric acid (SUA) …
disease caused by the increased formation or reduced excretion of serum uric acid (SUA) …